Perforated peptic ulcer

Kjetil Søreide, Kenneth Thorsen, Ewen M Harrison, Juliane Bingener, Morten H Møller, Michael Ohene-Yeboah, Jon Arne Søreide, Kjetil Søreide, Kenneth Thorsen, Ewen M Harrison, Juliane Bingener, Morten H Møller, Michael Ohene-Yeboah, Jon Arne Søreide

Abstract

Perforated peptic ulcer is a common emergency condition worldwide, with associated mortality rates of up to 30%. A scarcity of high-quality studies about the condition limits the knowledge base for clinical decision making, but a few published randomised trials are available. Although Helicobacter pylori and use of non-steroidal anti-inflammatory drugs are common causes, demographic differences in age, sex, perforation location, and underlying causes exist between countries, and mortality rates also vary. Clinical prediction rules are used, but accuracy varies with study population. Early surgery, either by laparoscopic or open repair, and proper sepsis management are essential for good outcome. Selected patients can be managed non-operatively or with novel endoscopic approaches, but validation of such methods in trials is needed. Quality of care, sepsis care bundles, and postoperative monitoring need further assessment. Adequate trials with low risk of bias are urgently needed to provide better evidence. We summarise the evidence for perforated peptic ulcer management and identify directions for future clinical research.

Conflict of interest statement

Conflict of interest statement

KS – None

KT – None

EMH - None

JB - None

MHM - None

MYO - None

JAS - None

Copyright © 2015 Elsevier Ltd. All rights reserved.

Figures

Figure 1. Peptic ulcer disease burden globally
Figure 1. Peptic ulcer disease burden globally
Years of life lost (YLL) and years of life with disability (YLD) presented for quintiles of the Human Development Index (HDI). Age-standardised estimates for peptic ulcer disease were retrieved from the Global Burden of Disease Study 2010 repository (http://ghdx.healthdata.org/record/global-burden-disease-study-2010-gbd-2010-results-cause-1990-2010-country-level). Proportion of deaths (bubble size), rate of years of life lost (YLL) and rate of years of life with disability (YLD) for both sexes and year 2010 were analysed. Data are presented by United Nations Development Programme Human Development Index quintiles (http://hdr.undp.org/en/content/human-development-index-hdi)
Figure 2. Mechanisms and factors in pathogenesis…
Figure 2. Mechanisms and factors in pathogenesis of perforated peptic ulcer [sketch, to be redrawn]
(A) an imbalance between between hostile and protective factors start the ulcerogenic process, and (B) although many cotributors are known, helicobacter infection and use of non-steroidal anti-inflammatory drugs appear of importance in disturbing the protective mucosal layer and (C) expose the gastric epithelium to acid. Several additional factors (D) may augment the ulcerogenic process (such as smoking, alcohol and several drugs) that lead to erosion (E). Eventually, the serosal lining is breached (F), and when perforated, the stomach content, including acidic fluid, will enter the abdominal cavity giving rise to intense pain, local peritonitis that may become generalized and eventually lead to a systemic inflammatory response syndrome and sepsis with the risk of multiorgan failure and mortality.
Figure 3. Preoperative adverse prognostic factors for…
Figure 3. Preoperative adverse prognostic factors for mortality in PPU disease
Adjusted preoperative prognostic factors for motality. Data derived and developed from Møller et al [47]. ASA, denotes American Society of Anesthesiologist risk score COPD, denotes chronic obstructive pulmonary disease S-albumin, denotes serum albumin NSAIDs, denotes non-steroidal antiinflammatory drugs RR, denotes relative risk CI, denotes confidence interval

References

    1. Møller MH, Adamsen S, Thomsen RW, et al. Multicentre trial of a perioperative protocol to reduce mortality in patients with peptic ulcer perforation. Br J Surg. 2011;98(6):802–10.
    1. Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet. 2009;374(9699):1449–61.
    1. Lau JY, Barkun A, Fan DM, et al. Challenges in the management of acute peptic ulcer bleeding. Lancet. 2013;381(9882):2033–43.
    1. Wang YR, Richter JE, Dempsey DT. Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006. Ann Surg. 2010;251(1):51–8.
    1. Lau JY, Sung J, Hill C, et al. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion. 2011;84(2):102–13.
    1. Guzel H, Kahramanca S, Seker D, et al. Peptic ulcer complications requiring surgery: what has changed in the last 50 years in Turkey. Turk J Gastroenterol. 2014;25(2):152–5.
    1. Hermansson M, Ekedahl A, Ranstam J, et al. Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974–2002. BMC Gastroenterol. 2009;9:25.
    1. Bashinskaya B, Nahed BV, Redjal N, et al. Trends in Peptic Ulcer Disease and the Identification of Helicobacter Pylori as a Causative Organism: Population-based Estimates from the US Nationwide Inpatient Sample. J Glob Infect Dis. 2011;3(4):366–70.
    1. Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, et al. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Aliment Pharmacol Ther. 2011;33(5):585–91.
    1. Sonnenberg A. Time trends of ulcer mortality in Europe. Gastroenterology. 2007;132(7):2320–7.
    1. Thorsen K, Glomsaker TB, von Meer A, et al. Trends in diagnosis and surgical management of patients with perforated peptic ulcer. J Gastrointest Surg. 2011;15(8):1329–35.
    1. Kang JY, Elders A, Majeed A, et al. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982–2002. Aliment Pharmacol Ther. 2006;24(1):65–79.
    1. Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993–2002: a population-based cohort study. Am J Gastroenterol. 2006;101(5):945–53.
    1. Thorsen K, Søreide JA, Kvaløy JT, et al. Epidemiology of perforated peptic ulcer: age- and gender-adjusted analysis of incidence and mortality. World J Gastroenterol. 2013;19(3):347–54.
    1. Wysocki A, Budzynski P, Kulawik J, et al. Changes in the localization of perforated peptic ulcer and its relation to gender and age of the patients throughout the last 45 years. World J Surg. 2011;35(4):811–6.
    1. Lobankov VM. Perforated peptic ulcers in Belarus: past and present. Lithuanian Surgery. 2006;4(1):22–28.
    1. Etonyeaku AC, Agbakwuru EA, Akinkuolie AA, et al. A review of the management of perforated duodenal ulcers at a tertiary hospital in south western Nigeria. Afr Health Sci. 2013;13(4):907–13.
    1. Dakubo JC, Naaeder SB, Clegg-Lamptey JN. Gastro-duodenal peptic ulcer perforation. East Afr Med J. 2009;86(3):100–9.
    1. Ohene-Yeboah M, Togbe B. Perforated gastric and duodenal ulcers in an urban African population. West Afr J Med. 2006;25(3):205–11.
    1. Asefa Z, Ge A. Perforated peptic ulcer disease in Zewditu Hospital. Ethiop Med J. 2012;50(2):145–51.
    1. Chalya PL, Mabula JB, Koy M, et al. Clinical profile and outcome of surgical treatment of perforated peptic ulcers in Northwestern Tanzania: A tertiary hospital experience. World J Emerg Surg. 2011;6:31.
    1. Bin-Taleb AK, Razzaq RA, Al-Kathiri ZO. Management of perforated peptic ulcer in patients at a teaching hospital. Saudi Med J. 2008;29(2):245–50.
    1. Kamani F, Moghimi M, Marashi SA, et al. Perforated peptic ulcer disease: mid-term outcome among Iranian population. Turk J Gastroenterol. 2010;21(2):125–8.
    1. Arveen S, Jagdish S, Kadambari D. Perforated peptic ulcer in South India: an institutional perspective. World J Surg. 2009;33(8):1600–4.
    1. Surapaneni S, SR, Reddy AV. The Perforation-Operation time Interval; An Important Mortality Indicator in Peptic Ulcer Perforation. J Clin Diagn Res. 2013;7(5):880–2.
    1. Horowitz J, Kukora JS, Ritchie WP., Jr All perforated ulcers are not alike. Ann Surg. 1989;209(6):693–6. discussion 696–7.
    1. Salama NR, Hartung ML, Muller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol. 2013;11(6):385–99.
    1. Cid TP, Fernandez MC, Benito Martinez S, et al. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2013;18(Suppl 1):12–7.
    1. Svanes C, Søreide JA, Skarstein A, et al. Smoking and ulcer perforation. Gut. 1997;41(2):177–80.
    1. Tokunaga Y, Hata K, Ryo J, et al. Density of Helicobacter pylori infection in patients with peptic ulcer perforation. J Am Coll Surg. 1998;186(6):659–63.
    1. Guerra JB, Rocha GA, Rocha AM, et al. IL-1 gene cluster and TNFA-307 polymorphisms in the risk of perforated duodenal ulcer. Gut. 2006;55(1):132–3.
    1. Wong BP, Chao NS, Leung MW, et al. Complications of peptic ulcer disease in children and adolescents: minimally invasive treatments offer feasible surgical options. J Pediatr Surg. 2006;41(12):2073–5.
    1. Lanas A, Serrano P, Bajador E, et al. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology. 1997;112(3):683–9.
    1. Ishikawa S, Inaba T, Mizuno M, et al. Characteristics of serious complicated gastroduodenal ulcers in Japan. Hepatogastroenterology. 2012;59(113):147–54.
    1. Gokakin AK, Kurt A, Atabey M, et al. The impact of Ramadan on peptic ulcer perforation. Ulus Travma Acil Cerrahi Derg. 2012;18(4):339–43.
    1. Wendling MR, Linn JG, Keplinger KM, et al. Omental patch repair effectively treats perforated marginal ulcer following Roux-en-Y gastric bypass. Surg Endosc. 2013;27(2):384–9.
    1. Cheng CL, Svesko V. Acute pyloric perforation after prolonged crack smoking. Ann Emerg Med. 1994;23(1):126–8.
    1. Jones HG, Hopkins L, Clayton A, et al. A perforated duodenal ulcer presenting as inferior lead ST elevation following amphetamine use. Ann R Coll Surg Engl. 2012;94(4):e144–5.
    1. Hirschowitz BI, Simmons J, Mohnen J. Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study. Clin Gastroenterol Hepatol. 2005;3(1):39–48.
    1. Buck DL, Vester-Andersen M, Moller MH. Surgical delay is a critical determinant of survival in perforated peptic ulcer. Br J Surg. 2013;100(8):1045–9.
    1. Gu WJ, Wang F, Bakker J, et al. The effect of goal-directed therapy on mortality in patients with sepsis - earlier is better: a meta-analysis of randomized controlled trials. Crit Care. 2014;18(5):570.
    1. Kumar A, Muir MT, Cohn SM, et al. The etiology of pneumoperitoneum in the 21st century. J Trauma Acute Care Surg. 2012;73(3):542–8.
    1. Mogasale V, Desai SN, Mogasale VV, et al. Case fatality rate and length of hospital stay among patients with typhoid intestinal perforation in developing countries: a systematic literature review. PLoS One. 2014;9(4):e93784.
    1. Sanogo ZZ, Camara M, Doumbia MM, et al. Digestive tract perforations at Point G Teaching Hospital in Bamako, Mali. Mali Med. 2012;27(1):19–22.
    1. Furukawa A, Sakoda M, Yamasaki M, et al. Gastrointestinal tract perforation: CT diagnosis of presence, site, and cause. Abdom Imaging. 2005;30(5):524–34.
    1. Ghekiere O, Lesnik A, Hoa D, et al. Value of computed tomography in the diagnosis of the cause of nontraumatic gastrointestinal tract perforation. J Comput Assist Tomogr. 2007;31(2):169–76.
    1. Møller MH, Adamsen S, Thomsen RW, et al. Preoperative prognostic factors for mortality in peptic ulcer perforation: a systematic review. Scand J Gastroenterol. 2010;45(7–8):785–805.
    1. Thorsen K, Søreide JA, Søreide K. Scoring systems for outcome prediction in patients with perforated peptic ulcer. Scand J Trauma Resusc Emerg Med. 2013;21:25.
    1. Thorsen K, Søreide JA, Søreide K. What is the best predictor of mortality in perforated peptic ulcer disease? A population-based, multivariable regression analysis including three clinical scoring systems. J Gastrointest Surg. 2014;18(7):1261–8.
    1. Søreide K, Thorsen K, Søreide JA. Predicting outcomes in patients with perforated gastroduodenal ulcers: artificial neural network modelling indicates a highly complex disease. Eur J Trauma Emerg Surg. 2014;41(1):91–98.
    1. Søreide K, Thorsen K, Søreide JA. Strategies to improve the outcome of emergency surgery for perforated peptic ulcer. Br J Surg. 2014;101(1):e51–64.
    1. Boey J, Choi SK, Poon A, et al. Risk stratification in perforated duodenal ulcers. A prospective validation of predictive factors. Ann Surg. 1987;205(1):22–6.
    1. Buck DL, Vester-Andersen M, Moller MH. Accuracy of clinical prediction rules in peptic ulcer perforation: an observational study. Scand J Gastroenterol. 2012;47(1):28–35.
    1. Moller MH, Adamsen S, Thomsen RW, et al. Multicentre trial of a perioperative protocol to reduce mortality in patients with peptic ulcer perforation. Br J Surg. 2011;98(6):802–10.
    1. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.
    1. Taylor H. Perforated peptic ulcer; treated without operation. Lancet. 1946;2(6422):441–4.
    1. Donovan AJ, Berne TV, Donovan JA. Perforated duodenal ulcer: an alternative therapeutic plan. Arch Surg. 1998;133(11):1166–71.
    1. Cao F, Li J, Li A, et al. Nonoperative management for perforated peptic ulcer: Who can benefit? Asian J Surg. 2014;37(3):148–153.
    1. Crofts TJ, Park KG, Steele RJ, et al. A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med. 1989;320(15):970–3.
    1. Wilhelmsen M, Møller MH, Rosenstock S. Surgical complications after open and laparoscopic surgery for perforated peptic ulcer in a nationwide cohort. Br J Surg. 2015;102(4):382–7.
    1. Wright GP, Davis AT, Koehler TJ, et al. Cost-efficiency and outcomes in the treatment of perforated peptic ulcer disease: Laparoscopic versus open approach. Surgery. 2014;156(4):1003–8.
    1. Sanabria A, Villegas MI, Morales Uribe CH. Laparoscopic repair for perforated peptic ulcer disease. Cochrane Database Syst Rev. 2013;2:Cd004778.
    1. Antoniou SA, Antoniou GA, Koch OO, et al. Meta-analysis of laparoscopic versus open repair of perforated peptic ulcer. Jsls. 2013;17(1):15–22.
    1. Bertleff MJ, Lange JF. Laparoscopic correction of perforated peptic ulcer: first choice? A review of literature. Surg Endosc. 2010;24(6):1231–9.
    1. Kumar P, Khan HM, Hasanrabba S. Treatment of perforated giant gastric ulcer in an emergency setting. World J Gastrointest Surg. 2014;6(1):5–8.
    1. Ergul E, Gozetlik EO. Emergency spontaneous gastric perforations: ulcus versus cancer. Langenbecks Arch Surg. 2009;394(4):643–6.
    1. Gupta V, Singh SP, Pandey A, et al. Study on the use of T-tube for patients with persistent duodenal fistula: is it useful? World J Surg. 2013;37(11):2542–5.
    1. Tanaka R, Kosugi S, Sakamoto K, et al. Treatment for perforated gastric ulcer: a multi-institutional retrospective review. J Gastrointest Surg. 2013;17(12):2074–81.
    1. Liu L, Chiu PW, Lam PK, et al. Effect of local injection of mesenchymal stem cells on healing of sutured gastric perforation in an experimental model. Br J Surg. 2015;102(2):e158–68.
    1. Levy MM, Rhodes A, Phillips GS, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7. 5-year study. Intensive Care Med. 2014;40(11):1623–33.
    1. Møller MH, Larsson HJ, Rosenstock S, et al. Quality-of-care initiative in patients treated surgically for perforated peptic ulcer. Br J Surg. 2013;100(4):543–52.
    1. Aga H, Readhead D, Maccoll G, et al. Fall in peptic ulcer mortality associated with increased consultant input, prompt surgery and use of high dependency care identified through peer-review audit. BMJ Open. 2012;2(1):e000271.
    1. Shan YS, Hsu HP, Hsieh YH, et al. Significance of intraoperative peritoneal culture of fungus in perforated peptic ulcer. Br J Surg. 2003;90(10):1215–9.
    1. Prakash A, Sharma D, Saxena A, et al. Effect of Candida infection on outcome in patients with perforation peritonitis. Indian J Gastroenterol. 2008;27(3):107–9.
    1. Gonenc M, Dural AC, Celik F, et al. Enhanced postoperative recovery pathways in emergency surgery: a randomised controlled clinical trial. Am J Surg. 2014;207(6):807–14.
    1. Wong CS, Chia CF, Lee HC, et al. Eradication of Helicobacter pylori for prevention of ulcer recurrence after simple closure of perforated peptic ulcer: a meta-analysis of randomized controlled trials. J Surg Res. 2013;182(2):219–26.
    1. Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2013;12:Cd008337.
    1. Bae S, Shim KN, Kim N, et al. Incidence and short-term mortality from perforated peptic ulcer in Korea: a population-based study. J Epidemiol. 2012;22(6):508–16.
    1. Buck DL, Moller MH. Influence of body mass index on mortality after surgery for perforated peptic ulcer. Br J Surg. 2014;101(8):993–9.
    1. Møller MH, Vester-Andersen M, Thomsen RW. Long-term mortality following peptic ulcer perforation in the PULP trial. A nationwide follow-up study. Scand J Gastroenterol. 2013;48(2):168–75.
    1. Svanes C, Lie SA, Lie RT, et al. Causes of death in patients with peptic ulcer perforation: a long-term follow-up study. Scand J Gastroenterol. 1999;34(1):18–24.
    1. Imhof M, Epstein S, Ohmann C, et al. Duration of survival after peptic ulcer perforation. World J Surg. 2008;32(3):408–12.
    1. Joneja JS, Sharma DB, Sharma D, et al. Quality of life after peptic perforation. J Assoc Physicians India. 2004;52:207–9.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi